At the 2022 Bioprocessing Summit, Demeetra’s Corey Brizzee presented Cas-CLOVER’s mechanism and newly engineered variants. This proven platform is enabling gene editing with extremely high efficiency and very low cell toxicity.
View the presentation below.
Learn more about Cas-CLOVER
Read our Peer-reviewed Publications
Schedule a call with us to learn more.